Nagy N - Search Results

1

MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.

Rebane A, Runnel T, Aab A, Maslovskaja J, Rückert B, Zimmermann M, Plaas M, Kärner J, Treis A, Pihlap M, Haljasorg U, Hermann H, Nagy N, Kemeny L, Erm T, Kingo K, Li M, Boldin MP, Akdis CA. Rebane A, et al. Among authors: nagy n. J Allergy Clin Immunol. 2014 Oct;134(4):836-847.e11. doi: 10.1016/j.jaci.2014.05.022. Epub 2014 Jul 2. J Allergy Clin Immunol. 2014. PMID: 24996260

2

Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis.

Rebane A, Zimmermann M, Aab A, Baurecht H, Koreck A, Karelson M, Abram K, Metsalu T, Pihlap M, Meyer N, Fölster-Holst R, Nagy N, Kemeny L, Kingo K, Vilo J, Illig T, Akdis M, Franke A, Novak N, Weidinger S, Akdis CA. Rebane A, et al. Among authors: nagy n. J Allergy Clin Immunol. 2012 May;129(5):1297-306. doi: 10.1016/j.jaci.2012.02.020. Epub 2012 Mar 24. J Allergy Clin Immunol. 2012. PMID: 22445417

3

The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes.

Nagy N, Bata-Csörgo Z, Kopasz N, Szeg C, Pivarcsi A, Koreck A, Dobozy A, Kemény L, Széll M. Nagy N, et al. Exp Dermatol. 2006 Aug;15(8):596-605. doi: 10.1111/j.1600-0625.2006.00450.x. Exp Dermatol. 2006. PMID: 16842598

4

The anti-apoptotic protein G1P3 is overexpressed in psoriasis and regulated by the non-coding RNA, PRINS.

Szegedi K, Sonkoly E, Nagy N, Németh IB, Bata-Csörgo Z, Kemény L, Dobozy A, Széll M. Szegedi K, et al. Among authors: nagy n. Exp Dermatol. 2010 Mar;19(3):269-78. doi: 10.1111/j.1600-0625.2010.01066.x. Exp Dermatol. 2010. PMID: 20377629

5

[New perspective in immunotherapy: local imiquimod treatment].

Kemény L, Nagy N. Kemény L, et al. Among authors: nagy n. Orv Hetil. 2010 May 9;151(19):774-83. doi: 10.1556/OH.2010.28866. Orv Hetil. 2010. PMID: 20427260 Review. Hungarian.

6

Phenotype-genotype correlations for clinical variants caused by CYLD mutations.

Nagy N, Farkas K, Kemény L, Széll M. Nagy N, et al. Eur J Med Genet. 2015 May;58(5):271-8. doi: 10.1016/j.ejmg.2015.02.010. Epub 2015 Mar 14. Eur J Med Genet. 2015. PMID: 25782638 Review.

7

Pharmacological Targeting of the Epidermal Barrier.

Kemény L, Nagy N, Csoma Z, Szabó K, Eros G. Kemény L, et al. Among authors: nagy n. Curr Pharm Des. 2016;22(35):5373-5381. doi: 10.2174/1381612822666160726094947. Curr Pharm Des. 2016. PMID: 27464729 Review.

8

The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer.

Nagy N, Németh IB, Szabad G, Szolnoky G, Belsõ N, Bata-Csörgõ Z, Dobozy A, Kemény L, Széll M. Nagy N, et al. Wound Repair Regen. 2008 Jul-Aug;16(4):495-502. doi: 10.1111/j.1524-475X.2008.00394.x. Wound Repair Regen. 2008. PMID: 18638267

9

MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2.

Xu N, Brodin P, Wei T, Meisgen F, Eidsmo L, Nagy N, Kemeny L, Ståhle M, Sonkoly E, Pivarcsi A. Xu N, et al. Among authors: nagy n. J Invest Dermatol. 2011 Jul;131(7):1521-9. doi: 10.1038/jid.2011.55. Epub 2011 Mar 17. J Invest Dermatol. 2011. PMID: 21412257 Free article.

10

Nuclear Factor κB Activation in a Type V Pityriasis Rubra Pilaris Patient Harboring Multiple CARD14 Variants.

Danis J, Göblös A, Gál B, Sulák A, Farkas K, Török D, Varga E, Korom I, Kemény L, Széll M, Bata-Csörgö Z, Nagy N. Danis J, et al. Among authors: nagy n. Front Immunol. 2018 Jul 3;9:1564. doi: 10.3389/fimmu.2018.01564. eCollection 2018. Front Immunol. 2018. PMID: 30018619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

662 results

Search Page

Filters